Ventana Medical Systems, Inc., a member of the Roche Group, is a world leader and innovator of tissue-based diagnostic solutions for patients worldwide. Ventana acquired BioImagene in August 2010. Through this acquisition, Ventana is uniquely positioned to deliver an end-to-end solution from automated staining to comprehensive patient reports. Digital Pathology solutions will complement and strengthen Ventana's current offering in image analysis and information management. Ventana digital pathology, powered by BioImagene, provides complete patient-focused solutions that are optimized for clinical labs worldwide. Ventana's digital pathology solutions represent the next step in improving workflow and efficiencies within pathology laboratories. Our solutions are used in academic medical centers, teaching hospitals, community hospitals, reference laboratories, and pharmaceutical and biotech companies.
Looking for a particular BioImagene employee's phone or email?
The BioImagene annual revenue was $71.1 billion in 2026.
Michael Cusack is the VP Marketing of BioImagene.
17 people are employed at BioImagene.
BioImagene is based in Sunnyvale, California.
The NAICS codes for BioImagene are [62, 62151, 621, 6215].
The SIC codes for BioImagene are [80, 807].